The importance of biological sex and estrogen in rodent models of cardiovascular health and disease

Circulation Research

Volumn 118, Issue 8, 2016, Pages 1294-1312

  Blenck, Christa L ^a   Harvey, Pamela A ^a   Reckelhoff, Jane F ^b   Leinwand, Leslie A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular diseases; estrogens; gonadal steroid hormones; heart failure; sex characteristics

Indexed keywords

ESTROGEN; HORMONE; ION CHANNEL; N(G) NITROARGININE METHYL ESTER;

BIOENERGY; BIOLOGICAL SEX; CARDIAC MUSCLE CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR HEALTH; CORONARY ARTERY LIGATION; DAHL SALT SENSITIVE RAT; EXPERIMENTAL MODEL; HEALTH; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; INTRACELLULAR SIGNALING; MOLECULAR BIOLOGY; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SEX; SEX DIFFERENCE; ANIMAL; BLOOD; DISEASE MODEL; FEMALE; HEART MITOCHONDRION; MALE; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SEXUAL DEVELOPMENT; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; HUMANS; MALE; MICE; MITOCHONDRIA, HEART; RATS; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION;

EID: 84963825556     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.307509     Document Type: Review

References (202)

1. Lloyd-Jones D, Adams RJ, Brown TM, Writing Group Members; American Heart Association Statistics Committee and Stroke Statistics Subcommittee Writing Group Members; American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010 121 e46 e215. doi: 10.1161/CIRCULATIONAHA.109.192667
2. Mosca L, Benjamin EJ, Berra K, American Heart Association American Heart Association Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 2011 57 1404 1423. doi: 10.1016/j.jacc.2011.02.005
3. Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM, Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation 1993 87 720 727
4. Huxley VH, Sex and the cardiovascular system: the intriguing tale of how women and men regulate cardiovascular function differently. Adv Physiol Educ 2007 31 17 22. doi: 10.1152/advan.00099.2006
5. Shaw LJ, Bairey Merz CN, Pepine CJ, WISE Investigators WISE Investigators Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006 47 S4 S20. doi: 10.1016/j.jacc.2005.01.072
6. National Institutes of Health Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research. 2001. http://grants.nih.gov/grants/funding/women-min/guidelines-amended-10-2001.htm
7. Gender Mainstreaming in the 6th Framework Programme-Reference Guide for Scientific Officers/Project Officers. 2015 2003. ftp://ftp.cordis.europa.eu/pub/science-society/docs/gendervademecum.pdf
8. Report on Governmental Health Research Policies-Promoting Gender or Sex Differences Sensitivity 2003; 2015. http://dsp-psd.pwgsc.gc.ca/collection-2008/cihr-irsc/MR21-103-2003E.pdf
9. Consideration of Sex as a Biological Variable in NIH-funded Research. 2015. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-102.html
10. Clayton JA, Collins FS, Policy: NIH to balance sex in cell and animal studies. Nature 2014 509 282 283
11. Salton CJ, Chuang ML, O'Donnell CJ, Kupka MJ, Larson MG, Kissinger KV, Edelman RR, Levy D, Manning WJ, Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol 2002 39 1055 1060
12. Sandstede J, Lipke C, Beer M, Hofmann S, Pabst T, Kenn W, Neubauer S, Hahn D, Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol 2000 10 438 442. doi: 10.1007/s003300050072
13. Cain PA, Ahl R, Hedstrom E, Ugander M, Allansdotter-Johnsson A, Friberg P, Arheden H, Age and gender specific normal values of left ventricular mass, volume and function for gradient echo magnetic resonance imaging: a cross sectional study. BMC Med Imaging 2009 9 2. doi: 10.1186/1471-2342-9-2
14. Marcus JT, DeWaal LK, Götte MJ, Van der Geest RJ, Heethaar RM, Van Rossum AC, MRI-derived left ventricular function parameters and mass in healthy young adults: relation with gender and body size. Int J Card Imaging 1999 15 411 419
15. Krishnan A, Samtani R, Dhanantwari P, Lee E, Yamada S, Shiota K, Donofrio MT, Leatherbury L, Lo CW, A detailed comparison of mouse and human cardiac development. Pediatr Res 2014 76 500 507. doi: 10.1038/pr.2014.128
16. Leinwand LA, Sex is a potent modifier of the cardiovascular system. J Clin Invest 2003 112 302 307. doi: 10.1172/JCI19429
17. Luczak ED, Leinwand LA, Sex-based cardiac physiology. Annu Rev Physiol 2009 71 1 18. doi: 10.1146/annurev.physiol.010908.163156
18. Murphy E, Estrogen signaling and cardiovascular disease. Circ Res 2011 109 687 696. doi: 10.1161/CIRCRESAHA.110.236687
19. Grandy SA, Howlett SE, Cardiac excitation-contraction coupling is altered in myocytes from aged male mice but not in cells from aged female mice. Am J Physiol Heart Circ Physiol 2006 291 H2362 H2370. doi: 10.1152/ajpheart.00070.2006
20. Howlett SE, Age-associated changes in excitation-contraction coupling are more prominent in ventricular myocytes from male rats than in myocytes from female rats. Am J Physiol Heart Circ Physiol 2010 298 H659 H670. doi: 10.1152/ajpheart.00214.2009
21. Parks RJ, Howlett SE, Sex differences in mechanisms of cardiac excitation-contraction coupling. Pflugers Arch 2013 465 747 763. doi: 10.1007/s00424-013-1233-0
22. Farrell SR, Ross JL, Howlett SE, Sex differences in mechanisms of cardiac excitation-contraction coupling in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 2010 299 H36 H45. doi: 10.1152/ajpheart.00299.2010
23. Bodi I, Mikala G, Koch SE, Akhter SA, Schwartz A, The L-type calcium channel in the heart: the beat goes on. J Clin Invest 2005 115 3306 3317. doi: 10.1172/JCI27167
24. Nattel S, Delayed-rectifier potassium currents and the control of cardiac repolarization: Noble and Tsien 40 years after. J Physiol 2008 586 5849 5852. doi: 10.1113/jphysiol.2008.163089
25. Schmitt N, Grunnet M, Olesen SP, Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia. Physiol Rev 2014 94 609 653. doi: 10.1152/physrev.00022.2013
26. Villareal RP, Woodruff AL, Massumi A, Gender and cardiac arrhythmias. Tex Heart Inst J 2001 28 265 275
27. Lehmann MH, Timothy KW, Frankovich D, Fromm BS, Keating M, Locati EH, Taggart RT, Towbin JA, Moss AJ, Schwartz PJ, Vincent GM, Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol 1997 29 93 99
28. Gaborit N, Varro A, Le Bouter S, Szuts V, Escande D, Nattel S, Demolombe S, Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts. J Mol Cell Cardiol 2010 49 639 646. doi: 10.1016/j.yjmcc.2010.06.005
29. Liu XK, Katchman A, Drici MD, Ebert SN, Ducic I, Morad M, Woosley RL, Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther 1998 285 672 679
30. Nerbonne JM, Studying cardiac arrhythmias in the mouse- A reasonable model for probing mechanisms? Trends Cardiovasc Med 2004 14 83 93. doi: 10.1016/j.tcm.2003.12.006
31. Nerbonne JM, Pugsley MK, Molecular diversity of ion channels in the mouse heart; a suitable model for cardiac drug development? Methods in Pharmacology and Toxicology: Cardiac Drug Development Guide 2003 Totowa, NJ Humana Press 245 269. In
32. Bers DM, Bers DM, Control of cardiac contraction by SR-Ca release and sarcolemmal-Ca fluxes. In: Excitation-Contraction Coupling and Cardiac Contractile Force. Developments in Cardiovascular Medicine 1991 122 Dordrecht, Boston, London Kluver Academic Publishers 149 170
33. Bers DM, Cardiac excitation-contraction coupling. Nature 2002 415 198 205. doi: 10.1038/415198a
34. Hove-Madsen L, Bers DM, Sarcoplasmic reticulum Ca2+ uptake and thapsigargin sensitivity in permeabilized rabbit and rat ventricular myocytes. Circ Res 1993 73 820 828
35. Xiao L, Zhang L, Han W, Wang Z, Nattel S, Sex-based transmural differences in cardiac repolarization and ionic-current properties in canine left ventricles. Am J Physiol Heart Circ Physiol 2006 291 H570 H580. doi: 10.1152/ajpheart.01288.2005
36. Johnson BD, Zheng W, Korach KS, Scheuer T, Catterall WA, Rubanyi GM, Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J Gen Physiol 1997 110 135 140
37. Chu SH, Goldspink P, Kowalski J, Beck J, Schwertz DW, Effect of estrogen on calcium-handling proteins, beta-adrenergic receptors, and function in rat heart. Life Sci 2006 79 1257 1267. doi: 10.1016/j.lfs.2006.03.037
38. Eisner DA, Sipido KR, Sodium calcium exchange in the heart: necessity or luxury? Circ Res 2004 95 549 551. doi: 10.1161/01.RES.0000143419.87518.9e
39. Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T, Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 2005 112 1701 1710. doi: 10.1161/CIRCULATIONAHA.104.523217
40. Berger F, Borchard U, Hafner D, Pütz I, Weis TM, Effects of 17beta-estradiol on action potentials and ionic currents in male rat ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 1997 356 788 796
41. Nakajima T, Iwasawa K, Oonuma H, Morita T, Goto A, Wang Y, Hazama H, Antiarrhythmic effect and its underlying ionic mechanism of 17beta-estradiol in cardiac myocytes. Br J Pharmacol 1999 127 429 440. doi: 10.1038/sj.bjp.0702576
42. Isensee J, Witt H, Pregla R, Hetzer R, Regitz-Zagrosek V, Noppinger PR, Sexually dimorphic gene expression in the heart of mice and men. J Mol Med (Berl) 2008 86 61 74. doi: 10.1007/s00109-007-0240-z
43. Praktiknjo SD, Llamas B, Scott-Boyer MP, Picard S, Robert F, Langlais D, Haibe-Kains B, Faubert D, Silversides DW, Deschepper CF, Novel effects of chromosome Y on cardiac regulation, chromatin remodeling, and neonatal programming in male mice. Endocrinology 2013 154 4746 4756. doi: 10.1210/en.2013-1699
44. Reiser PJ, Moravec CS, Sex differences in myosin heavy chain isoforms of human failing and nonfailing atria. Am J Physiol Heart Circ Physiol 2014 307 H265 H272. doi: 10.1152/ajpheart.00810.2013
45. Miyata S, Minobe W, Bristow MR, Leinwand LA, Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 2000 86 386 390
46. Lompre AM, Mercadier JJ, Wisnewsky C, Bouveret P, Pantaloni C, D'Albis A, Schwartz K, Species- and age-dependent changes in the relative amounts of cardiac myosin isoenzymes in mammals. Dev Biol 1981 84 286 290
47. Rice R, Guinto P, Dowell-Martino C, He H, Hoyer K, Krenz M, Robbins J, Ingwall JS, Tardiff JC, Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts. J Mol Cell Cardiol 2010 48 979 988. doi: 10.1016/j.yjmcc.2009.11.018
48. Schaible TF, Malhotra A, Ciambrone G, Scheuer J, The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res 1984 54 38 49
49. Calovini T, Haase H, Morano I, Steroid-hormone regulation of myosin subunit expression in smooth and cardiac muscle. J Cell Biochem 1995 59 69 78. doi: 10.1002/jcb.240590109
50. Scheuer J, Malhotra A, Schaible TF, Capasso J, Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 1987 61 12 19
51. Rosenkranz-Weiss P, Tomek RJ, Mathew J, Eghbali M, Gender-specific differences in expression of mRNAs for functional and structural proteins in rat ventricular myocardium. J Mol Cell Cardiol 1994 26 261 270
52. McKee LA, Chen H, Regan JA, Behunin SM, Walker JW, Walker JS, Konhilas JP, Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice. Arch Biochem Biophys 2013 535 39 48. doi: 10.1016/j.abb.2012.12.023
53. Patrizio M, Musumeci M, Piccone A, Raggi C, Mattei E, Marano G, Hormonal regulation of β-myosin heavy chain expression in the mouse left ventricle. J Endocrinol 2013 216 287 296. doi: 10.1530/JOE-12-0201
54. Czubryt MP, Espira L, Lamoureux L, Abrenica B, The role of sex in cardiac function and disease. Can J Physiol Pharmacol 2006 84 93 109. doi: 10.1139/y05-151
55. Peterson LR, Soto PF, Herrero P, Schechtman KB, Dence C, Gropler RJ, Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 2007 14 573 581. doi: 10.1016/j.nuclcard.2007.03.001
56. Yan L, Ge H, Li H, Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. J Mol Cell Cardiol 2004 37 921 929. doi: 10.1016/j.yjmcc.2004.06.012
57. Vijay V, Han T, Moland CL, Kwekel JC, Fuscoe JC, Desai VG, Sexual dimorphism in the expression of mitochondria-related genes in rat heart at different ages. PLoS One 2015 10 e0117047. doi: 10.1371/journal.pone.0117047
58. Colom B, Oliver J, Roca P, Garcia-Palmer FJ, Caloric restriction and gender modulate cardiac muscle mitochondrial H2O2 production and oxidative damage. Cardiovasc Res 2007 74 456 465. doi: 10.1016/j.cardiores.2007.02.001
59. Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E, Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res 2010 106 1681 1691. doi: 10.1161/CIRCRESAHA.109.213645
60. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, Vetter H, Grohé C, 17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res 1999 43 666 674
61. Schmidt O, Pfanner N, Meisinger C, Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol 2010 11 655 667. doi: 10.1038/nrm2959
62. Mendelsohn ME, Karas RH, Molecular and cellular basis of cardiovascular gender differences. Science 2005 308 1583 1587. doi: 10.1126/science.1112062
63. Gorski J, Hansen JC, The "one and only" step model of estrogen action. Steroids 1987 49 461 475
64. Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, Wang ZY, Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol 2010 24 709 721. doi: 10.1210/me.2009-0317
65. Knowlton AA, Korzick DH, Estrogen and the female heart. Mol Cell Endocrinol 2014 389 31 39. doi: 10.1016/j.mce.2014.01.002
66. Han G, Li F, Yu X, White RE, GPER: a novel target for non-genomic estrogen action in the cardiovascular system. Pharmacol Res 2013 71 53 60. doi: 10.1016/j.phrs.2013.02.008
67. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998 280 605 613
68. Harman SM, Black DM, Naftolin F, Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med 2014 161 249 260. doi: 10.7326/M14-0353
69. Stumpf WE, Steroid hormones and the cardiovascular system: direct actions of estradiol, progesterone, testosterone, gluco- and mineralcorticoids, and soltriol [vitamin D] on central nervous regulatory and peripheral tissues. Experientia 1990 46 13 25
70. Bhupathy P, Haines CD, Leinwand LA, Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond Engl) 2010 6 77 95. doi: 10.2217/whe.09.80
71. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M, Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee. Arterioscler Thromb Vasc Biol 2006 26 1689 1692. doi: 10.1161/01.ATV.0000227471.00284.ef
72. Liew R, Williams JK, Collins P, MacLeod KT, Soy-derived isoflavones exert opposing actions on Guinea pig ventricular myocytes. J Pharmacol Exp Ther 2003 304 985 993. doi: 10.1124/jpet.102.042986
73. Thigpen JE, Setchell KD, Ahlmark KB, Locklear J, Spahr T, Caviness GF, Goelz MF, Haseman JK, Newbold RR, Forsythe DB, Phytoestrogen content of purified, open- and closed-formula laboratory animal diets. Lab Anim Sci 1999 49 530 536
74. Haines CD, Harvey PA, Luczak ED, Barthel KK, Konhilas JP, Watson PA, Stauffer BL, Leinwand LA, Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology 2012 153 4470 4479. doi: 10.1210/en.2012-1391
75. Nelson JF, Felicio LS, Randall PK, Sims C, Finch CE, A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology. Biol Reprod 1982 27 327 339
76. Nelson JF, Felicio LS, Osterburg HH, Finch CE, Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. Biol Reprod 1981 24 784 794
77. McNamara KM, Harwood DT, Simanainen U, Walters KA, Jimenez M, Handelsman DJ, Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol 2010 121 611 618. doi: 10.1016/j.jsbmb.2010.02.001
78. Mayer LP, Dyer CA, Eastgard RL, Hoyer PB, Banka CL, Atherosclerotic lesion development in a novel ovary-intact mouse model of perimenopause. Arterioscler Thromb Vasc Biol 2005 25 1910 1916. doi: 10.1161/01.ATV.0000175767.46520.6a
79. Heineke J, Molkentin JD, Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006 7 589 600. doi: 10.1038/nrm1983
80. McMullen JR, Jennings GL, Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 2007 34 255 262. doi: 10.1111/j.1440-1681.2007.04585.x
81. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y, Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995 376 70 74. doi: 10.1038/376070a0
82. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y, Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987 262 5592 5595
83. Carretero OA, Oparil S, Essential hypertension. Part I: definition and etiology. Circulation 2000 101 329 335
84. Boynton RE, Todd RL, Blood pressure readings of 75,258 university students. Arch Intern Med (Chic) 1947 80 454 462
85. Roberts J, Maurer K, Blood pressure levels of persons 6-74 years. United States, 1971-1974. Vital Health Stat 11 1977 203 i-v, 1-103
86. Mair KM, Johansen AK, Wright AF, Wallace E, MacLean MR, Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response. Br J Pharmacol 2014 171 567 579. doi: 10.1111/bph.12281
87. Hall JE, Guyton AC, Brands MJ, Hypertension, Pathophysiology, Diagnosis, and Management 1995 2nd ed New York: Raven Press
88. Hall JE, Guyton AC, Brands MW, Pressure-volume regulation in hypertension. Kidney Int Suppl 1996 55 S35 S41
89. Jones DW, Hall JE, Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials. Hypertension 2004 43 1 3. doi: 10.1161/01.HYP.0000110061.06674.ca
90. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS, Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986 8 II127 II134
91. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK, p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996 271 23317 23321
92. Pechère-Bertschi A, Burnier M, Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 2004 17 994 1001. doi: 10.1016/j.amjhyper.2004.08.009
93. Okamoto K, Aoki K, Development of a strain of spontaneously hypertensive rats. Jpn Circ J 1963 27 282 293
94. Hubner N, Wallace CA, Zimdahl H, Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet 2005 37 243 253. doi: 10.1038/ng1522
95. Cowley AW Jr, The genetic dissection of essential hypertension. Nat Rev Genet 2006 7 829 840. doi: 10.1038/nrg1967
96. Reckelhoff JF, Zhang H, Granger JP, Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats. Hypertension 1998 31 435 439
97. Chan V, Fenning A, Levick SP, Loch D, Chunduri P, Iyer A, Teo YL, Hoey A, Wilson K, Burstow D, Brown L, Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats. J Cardiovasc Pharmacol 2011 57 469 478. doi: 10.1097/FJC.0b013e3182102c3b
98. Palmer BM, Chen Z, Lachapelle RR, Hendley ED, LeWinter MM, Cardiomyocyte function associated with hyperactivity and/or hypertension in genetic models of LV hypertrophy. Am J Physiol Heart Circ Physiol 2006 290 H463 H473. doi: 10.1152/ajpheart.00310.2005
99. Doggrell SA, Brown L, Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 1998 39 89 105
100. Brinson KN, Rafikova O, Sullivan JC, Female sex hormones protect against salt-sensitive hypertension but not essential hypertension. Am J Physiol Regul Integr Comp Physiol 2014 307 R149 R157. doi: 10.1152/ajpregu.00061.2014
101. Jazbutyte V, Hu K, Kruchten P, Bey E, Maier SK, Fritzemeier KH, Prelle K, Hegele-Hartung C, Hartmann RW, Neyses L, Ertl G, Pelzer T, Aging reduces the efficacy of estrogen substitution to attenuate cardiac hypertrophy in female spontaneously hypertensive rats. Hypertension 2006 48 579 586. doi: 10.1161/01.HYP.0000240053.48517.c7
102. Reckelhoff JF, Zhang H, Srivastava K, Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension 2000 35 480 483
103. Yanes LL, Romero DG, Iles JW, Iliescu R, Gomez-Sanchez C, Reckelhoff JF, Sexual dimorphism in the renin-angiotensin system in aging spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2006 291 R383 R390. doi: 10.1152/ajpregu.00510.2005
104. Bursztyn M, Ben-Dov IZ, Sex differences in salt-sensitivity risk approximated from ambulatory blood pressure monitoring and mortality. J Hypertens 2013 31 900 905. doi: 10.1097/HJH.0b013e32835f29f4
105. Rapp JP, Dene H, Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 1985 7 340 349
106. Bayorh MA, Socci RR, Eatman D, Wang M, Thierry-Palmer M, The role of gender in salt-induced hypertension. Clin Exp Hypertens 2001 23 241 255
107. Hinojosa-Laborde C, Lange DL, Haywood JR, Role of female sex hormones in the development and reversal of dahl hypertension. Hypertension 2000 35 484 489
108. Yanes LL, Sartori-Valinotti JC, Iliescu R, Romero DG, Racusen LC, Zhang H, Reckelhoff JF, Testosterone-dependent hypertension and upregulation of intrarenal angiotensinogen in Dahl salt-sensitive rats. Am J Physiol Renal Physiol 2009 296 F771 F779. doi: 10.1152/ajprenal.90389.2008
109. Glushkovskaya-Semyachkina OV, Anishchenko TG, Sindyakova TA, Leksina OV, Berdnikova VA, Sex-related differences in nitric oxide content in healthy and hypertensive rats at rest and under stress conditions. Bull Exp Biol Med 2006 142 9 11
110. Sáinz J, Osuna A, Wangensteen R, de Dios Luna J, Rodríguez-Gómez I, Duarte J, Moreno JM, Vargas F, Role of sex, gonadectomy and sex hormones in the development of nitric oxide inhibition-induced hypertension. Exp Physiol 2004 89 155 162. doi: 10.1113/expphysiol.2003.002652
111. Wu Y, Huang A, Sun D, Falck JR, Koller A, Kaley G, Gender-specific compensation for the lack of NO in the mediation of flow-induced arteriolar dilation. Am J Physiol Heart Circ Physiol 2001 280 H2456 H2461
112. Wang YR, Yen CH, Sun YF, Laun YT, Gender-dependent response in blood pressure changes following the inhibition of nitric oxide synthase. Chin J Physiol 2003 46 91 94
113. Brinson KN, Elmarakby AA, Tipton AJ, Crislip GR, Yamamoto T, Baban B, Sullivan JC, Female SHR have greater blood pressure sensitivity and renal T cell infiltration following chronic NOS inhibition than males. Am J Physiol Regul Integr Comp Physiol 2013 305 R701 R710. doi: 10.1152/ajpregu.00226.2013
114. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S, Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 1994 91 5212 5216
115. Pinto YM, Paul M, Ganten D, Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res 1998 39 77 88
116. Jhund PS, McMurray JJ, Heart failure after acute myocardial infarction: a lost battle in the war on heart failure? Circulation 2008 118 2019 2021. doi: 10.1161/CIRCULATIONAHA.108.813493
117. Mozaffarian D, Benjamin EJ, Go AS, American Heart Association Statistics Committee and Stroke Statistics Subcommittee American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015 131 e29 322. doi: 10.1161/CIR.0000000000000152
118. Lenzen MJ, Rosengren A, Scholte op Reimer WJ, Follath F, Boersma E, Simoons ML, Cleland JG, Komajda M, Management of patients with heart failure in clinical practice: differences between men and women. Heart 2008 94 e10. doi: 10.1136/hrt.2006.099523
119. Zhang Z, Fang J, Gillespie C, Wang G, Hong Y, Yoon PW, Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction. Am J Cardiol 2012 109 1097 1103. doi: 10.1016/j.amjcard.2011.12.001
120. Karlson BW, Herlitz J, Hartford M, Prognosis in myocardial infarction in relation to gender. Am Heart J 1994 128 477 483
121. Xie M, Burchfield JS, Hill JA, Pathological ventricular remodeling: therapies: part 2 of 2. Circulation 2013 128 1021 1030. doi: 10.1161/CIRCULATIONAHA.113.001879
122. Qin D, Zhang ZH, Caref EB, Boutjdir M, Jain P, el-Sherif N, Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ Res 1996 79 461 473
123. Tomaselli GF, Marbán E, Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 1999 42 270 283
124. Cavasin MA, Yang XP, Liu YH, Mehta D, Karumanchi R, Bulagannawar M, Carretero OA, Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure. J Cardiovasc Pharmacol 2000 36 472 480
125. Cavasin MA, Tao Z, Menon S, Yang XP, Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci 2004 75 2181 2192. doi: 10.1016/j.lfs.2004.04.024
126. Fang L, Gao XM, Moore XL, Kiriazis H, Su Y, Ming Z, Lim YL, Dart AM, Du XJ, Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 2007 43 535 544. doi: 10.1016/j.yjmcc.2007.06.011
127. Chen Q, Williams R, Healy CL, Wright CD, Wu SC, O'Connell TD, An association between gene expression and better survival in female mice following myocardial infarction. J Mol Cell Cardiol 2010 49 801 811. doi: 10.1016/j.yjmcc.2010.08.002
128. Shioura KM, Geenen DL, Goldspink PH, Sex-related changes in cardiac function following myocardial infarction in mice. Am J Physiol Regul Integr Comp Physiol 2008 295 R528 R534. doi: 10.1152/ajpregu.90342.2008
129. Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami CA, Kajstura J, Anversa P, Myocyte death in the failing human heart is gender dependent. Circ Res 1999 85 856 866
130. Korte T, Fuchs M, Arkudas A, Geertz S, Meyer R, Gardiwal A, Klein G, Niehaus M, Krust A, Chambon P, Drexler H, Fink K, Grohé C, Female mice lacking estrogen receptor beta display prolonged ventricular repolarization and reduced ventricular automaticity after myocardial infarction. Circulation 2005 111 2282 2290. doi: 10.1161/01.CIR.0000164262.08004.BB
131. Litwin SE, Katz SE, Litwin CM, Morgan JP, Douglas PS, Gender differences in postinfarction left ventricular remodeling. Cardiology 1999 91 173 183. doi: 6906
132. Chen YF, Redetzke RA, Sivertson RM, Coburn TS, Cypher LR, Gerdes AM, Post-myocardial infarction left ventricular myocyte remodeling: are there gender differences in rats? Cardiovasc Pathol 2011 20 e189 e195. doi: 10.1016/j.carpath.2010.09.007
133. Bogatyryov Y, Tomanek RJ, Dedkov EI, Structural composition of myocardial infarction scar in middle-aged male and female rats: does sex matter? J Histochem Cytochem 2013 61 833 848. doi: 10.1369/0022155413499794
134. Dedkov EI, Oak K, Christensen LP, Tomanek RJ, Coronary vessels and cardiac myocytes of middle-aged rats demonstrate regional sex-specific adaptation in response to postmyocardial infarction remodeling. Biol Sex Differ 2014 5 1. doi: 10.1186/2042-6410-5-1
135. Pelzer T, Loza PA, Hu K, Bayer B, Dienesch C, Calvillo L, Couse JF, Korach KS, Neyses L, Ertl G, Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction. Circulation 2005 111 1492 1498. doi: 10.1161/01.CIR.0000159262.18512.46
136. Babiker FA, Lips DJ, Delvaux E, Zandberg P, Janssen BJ, Prinzen F, Van Eys G, Grohé C, Doevendans PA, Oestrogen modulates cardiac ischaemic remodelling through oestrogen receptor-specific mechanisms. Acta Physiol (Oxf) 2007 189 23 31. doi: 10.1111/j.1748-1716.2006.01633.x
137. Rissman EF, Wersinger SR, Taylor JA, Lubahn DB, Estrogen receptor function as revealed by knockout studies: neuroendocrine and behavioral aspects. Horm Behav 1997 31 232 243. doi: 10.1006/hbeh.1997.1390
138. Kararigas G, Nguyen BT, Jarry H, Estrogen modulates cardiac growth through an estrogen receptor α-dependent mechanism in healthy ovariectomized mice. Mol Cell Endocrinol 2014 382 909 914. doi: 10.1016/j.mce.2013.11.011
139. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, Dahlman-Wright K, Nilsson S, Gustafsson JA, Efendic S, Khan A, Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 2006 49 588 597. doi: 10.1007/s00125-005-0105-3
140. Morani A, Barros RP, Imamov O, Hultenby K, Arner A, Warner M, Gustafsson JA, Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (ERbeta-/-) mice. Proc Natl Acad Sci U S A 2006 103 7165 7169. doi: 10.1073/pnas.0602194103
141. Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER, Estrogen receptor-beta prevents cardiac fibrosis. Mol Endocrinol 2010 24 2152 2165. doi: 10.1210/me.2010-0154
142. Chen CC, Lin CC, Lee TM, 17beta-Estradiol decreases vulnerability to ventricular arrhythmias by preserving connexin43 protein in infarcted rats. Eur J Pharmacol 2010 629 73 81. doi: 10.1016/j.ejphar.2009.11.050
143. Cavasin MA, Sankey SS, Yu AL, Menon S, Yang XP, Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 2003 284 H1560 H1569. doi: 10.1152/ajpheart.01087.2002
144. Van Rooij E, Fielitz J, Sutherland LB, Thijssen VL, Crijns HJ, Dimaio MJ, Shelton J, De Windt LJ, Hill JA, Olson EN, Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor. Circ Res 2010 106 155 165. doi: 10.1161/CIRCRESAHA.109.207084
145. Kalogeris T, Baines CP, Krenz M, Korthuis RJ, Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 2012 298 229 317. doi: 10.1016/B978-0-12-394309-5.00006-7
146. Cross HR, Murphy E, Steenbergen C, Ca(2+) loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2002 283 H481 H489. doi: 10.1152/ajpheart.00790.2001
147. Cross HR, Lu L, Steenbergen C, Philipson KD, Murphy E, Overexpression of the cardiac Na+/Ca2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res 1998 83 1215 1223
148. Sun J, Picht E, Ginsburg KS, Bers DM, Steenbergen C, Murphy E, Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res 2006 98 403 411. doi: 10.1161/01.RES.0000202707.79018.0a
149. Imahashi K, London RE, Steenbergen C, Murphy E, Male/female differences in intracellular Na+ regulation during ischemia/reperfusion in mouse heart. J Mol Cell Cardiol 2004 37 747 753. doi: 10.1016/j.yjmcc.2004.06.010
150. Le TY, Ashton AW, Mardini M, Stanton PG, Funder JW, Handelsman DJ, Mihailidou AS, Role of androgens in sex differences in cardiac damage during myocardial infarction. Endocrinology 2014 155 568 575. doi: 10.1210/en.2013-1755
151. Chen C, Hu LX, Dong T, Wang GQ, Wang LH, Zhou XP, Jiang Y, Murao K, Lu SQ, Chen JW, Zhang GX, Apoptosis and autophagy contribute to gender difference in cardiac ischemia-reperfusion induced injury in rats. Life Sci 2013 93 265 270. doi: 10.1016/j.lfs.2013.06.019
152. Johnson MS, Moore RL, Brown DA, Sex differences in myocardial infarct size are abolished by sarcolemmal KATP channel blockade in rat. Am J Physiol Heart Circ Physiol 2006 290 H2644 H2647. doi: 10.1152/ajpheart.01291.2005
153. Brown DA, Lynch JM, Armstrong CJ, Caruso NM, Ehlers LB, Johnson MS, Moore RL, Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat. J Physiol 2005 564 619 630. doi: 10.1113/jphysiol.2004.081323
154. Wang M, Baker L, Tsai BM, Meldrum KK, Meldrum DR, Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 2005 288 E321 E326. doi: 10.1152/ajpendo.00278.2004
155. Sugishita K, Su Z, Li F, Philipson KD, Barry WH, Gender influences [Ca(2+)](i) during metabolic inhibition in myocytes overexpressing the Na(+)-Ca(2+) exchanger. Circulation 2001 104 2101 2106
156. Wang F, He Q, Sun Y, Dai X, Yang XP, Female adult mouse cardiomyocytes are protected against oxidative stress. Hypertension 2010 55 1172 1178. doi: 10.1161/HYPERTENSIONAHA.110.150839
157. Murphy E, Steenbergen C, Cardioprotection in females: a role for nitric oxide and altered gene expression. Heart Fail Rev 2007 12 293 300. doi: 10.1007/s10741-007-9035-0
158. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS, Murphy E, Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol 2005 38 289 297. doi: 10.1016/j.yjmcc.2004.11.013
159. Rohini A, Agrawal N, Koyani CN, Singh R, Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res 2010 61 269 280. doi: 10.1016/j.phrs.2009.11.012
160. Konhilas JP, Maass AH, Luckey SW, Stauffer BL, Olson EN, Leinwand LA, Sex modifies exercise and cardiac adaptation in mice. Am J Physiol Heart Circ Physiol 2004 287 H2768 H2776. doi: 10.1152/ajpheart.00292.2004
161. Stauffer BL, Konhilas JP, Luczak ED, Leinwand LA, Soy diet worsens heart disease in mice. J Clin Invest 2006 116 209 216. doi: 10.1172/JCI24676
162. Himmelmann A, Hypertension: an important precursor of heart failure. Blood Press 1999 8 253 260
163. deAlmeida AC, Van Oort RJ, Wehrens XH, Transverse aortic constriction in mice. J Vis Exp 2010 38 1729. doi: 10.3791/1729
164. Patten RD, Hall-Porter MR, Small animal models of heart failure: development of novel therapies, past and present. Circ Heart Fail 2009 2 138 144. doi: 10.1161/CIRCHEARTFAILURE.108.839761
165. Douglas PS, Katz SE, Weinberg EO, Chen MH, Bishop SP, Lorell BH, Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol 1998 32 1118 1125
166. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, Lorell BH, Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 1999 34 264 273
167. Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Kararigas G, Dworatzek E, Staub E, Martus P, Ruiz Noppinger P, Kintscher U, Gustafsson JA, Regitz-Zagrosek V, Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol 2010 298 R1597 R1606. doi: 10.1152/ajpregu.00825.2009
168. Kararigas G, Fliegner D, Forler S, Klein O, Schubert C, Gustafsson JÅ Klose J, Regitz-Zagrosek V, Comparative proteomic analysis reveals sex and estrogen receptor β effects in the pressure overloaded heart. J Proteome Res 2014 13 5829 5836. doi: 10.1021/pr500749j
169. Prévilon M, Pezet M, Vinet L, Mercadier JJ, Rouet-Benzineb P, Gender-specific potential inhibitory role of Ca2+/calmodulin dependent protein kinase phosphatase (CaMKP) in pressure-overloaded mouse heart. PLoS One 2014 9 e90822. doi: 10.1371/journal.pone.0090822
170. Skavdahl M, Steenbergen C, Clark J, Myers P, Demianenko T, Mao L, Rockman HA, Korach KS, Murphy E, Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am J Physiol Heart Circ Physiol 2005 288 H469 H476. doi: 10.1152/ajpheart.00723.2004
171. Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, McGaughey D, Karp RB, Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992 86 1099 1107
172. Patten RD, Pourati I, Aronovitz MJ, Alsheikh-Ali A, Eder S, Force T, Mendelsohn ME, Karas RH, 17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. J Card Fail 2008 14 245 253. doi: 10.1016/j.cardfail.2007.10.024
173. Babiker FA, Lips D, Meyer R, Delvaux E, Zandberg P, Janssen B, Van Eys G, Grohé C, Doevendans PA, Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. Arterioscler Thromb Vasc Biol 2006 26 1524 1530. doi: 10.1161/01.ATV.0000223344.11128.23
174. Queirós AM, Eschen C, Fliegner D, Kararigas G, Dworatzek E, Westphal C, Sanchez Ruderisch H, Regitz-Zagrosek V, Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart. Int J Cardiol 2013 169 331 338. doi: 10.1016/j.ijcard.2013.09.002
175. O'Meara CC, Wamstad JA, Gladstone RA, Fomovsky GM, Butty VL, Shrikumar A, Gannon JB, Boyer LA, Lee RT, Transcriptional reversion of cardiac myocyte fate during mammalian cardiac regeneration. Circ Res 2015 116 804 815. doi: 10.1161/CIRCRESAHA.116.304269
176. Liu J, Sadoshima J, Zhai P, Hong C, Yang G, Chen W, Yan L, Wang Y, Vatner SF, Vatner DE, Pressure overload induces greater hypertrophy and mortality in female mice with p38alpha MAPK inhibition. J Mol Cell Cardiol 2006 41 680 688. doi: 10.1016/j.yjmcc.2006.07.007
177. Loyer X, Oliviero P, Damy T, Robidel E, Marotte F, Heymes C, Samuel JL, Effects of sex differences on constitutive nitric oxide synthase expression and activity in response to pressure overload in rats. Am J Physiol Heart Circ Physiol 2007 293 H2650 H2658. doi: 10.1152/ajpheart.00883.2007
178. Lorell BH, Carabello BA, Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000 102 470 479
179. Gardner JD, Brower GL, Janicki JS, Gender differences in cardiac remodeling secondary to chronic volume overload. J Card Fail 2002 8 101 107
180. Dent MR, Tappia PS, Dhalla NS, Gender differences in cardiac dysfunction and remodeling due to volume overload. J Card Fail 2010 16 439 449. doi: 10.1016/j.cardfail.2009.12.017
181. Dent MR, Tappia PS, Dhalla NS, Gender differences in apoptotic signaling in heart failure due to volume overload. Apoptosis 2010 15 499 510. doi: 10.1007/s10495-009-0441-8
182. Petrov G, Regitz-Zagrosek V, Lehmkuhl E, Krabatsch T, Dunkel A, Dandel M, Dworatzek E, Mahmoodzadeh S, Schubert C, Becher E, Hampl H, Hetzer R, Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation 2010 122 S23 S28. doi: 10.1161/CIRCULATIONAHA.109.927764
183. Dent MR, Tappia PS, Dhalla NS, Gender differences in β-adrenoceptor system in cardiac hypertrophy due to arteriovenous fistula. J Cell Physiol 2011 226 181 186. doi: 10.1002/jcp.22321
184. Haines CD, Harvey PA, Leinwand LA, Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner. Endocrinology 2012 153 4480 4490. doi: 10.1210/en.2012-1353
185. Chen J, Petranka J, Yamamura K, London RE, Steenbergen C, Murphy E, Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol. Am J Physiol Heart Circ Physiol 2003 285 H2657 H2662. doi: 10.1152/ajpheart.00557.2003
186. Vizgirda VM, Wahler GM, Sondgeroth KL, Ziolo MT, Schwertz DW, Mechanisms of sex differences in rat cardiac myocyte response to beta-adrenergic stimulation. Am J Physiol Heart Circ Physiol 2002 282 H256 H263
187. Curl CL, Wendt IR, Kotsanas G, Effects of gender on intracellular. Pflugers Arch 2001 441 709 716
188. Mellor KM, Curl CL, Chandramouli C, Pedrazzini T, Wendt IR, Delbridge LM, Ageing-related cardiomyocyte functional decline is sex and angiotensin II dependent. Age (Dordr) 2014 36 9630. doi: 10.1007/s11357-014-9630-7
189. Li HY, Bian JS, Kwan YW, Wong TM, Enhanced responses to 17beta-estradiol in rat hearts treated with isoproterenol: involvement of a cyclic AMP-dependent pathway. J Pharmacol Exp Ther 2000 293 592 598
190. Kam KW, Kravtsov GM, Liu J, Wong TM, Increased PKA activity and its influence on isoprenaline-stimulated L-type Ca2+ channels in the heart from ovariectomized rats. Br J Pharmacol 2005 144 972 981. doi: 10.1038/sj.bjp.0706123
191. Wu Q, Zhao Z, Sun H, Hao YL, Yan CD, Gu SL, Oestrogen changed cardiomyocyte contraction and beta-adrenoceptor expression in rat hearts subjected to ischaemia-reperfusion. Exp Physiol 2008 93 1034 1043. doi: 10.1113/expphysiol.2007.041939
192. Pedram A, Razandi M, Lubahn D, Liu J, Vannan M, Levin ER, Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin. Endocrinology 2008 149 3361 3369. doi: 10.1210/en.2008-0133
193. Maass A, Leinwand LA, Animal models of hypertrophic cardiomyopathy. Curr Opin Cardiol 2000 15 189 196
194. Olsson MC, Palmer BM, Leinwand LA, Moore RL, Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2001 280 H1136 H1144
195. Palmer BM, Wang Y, Teekakirikul P, Hinson JT, Fatkin D, Strouse S, Vanburen P, Seidman CE, Seidman JG, Maughan DW, Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex. Am J Physiol Heart Circ Physiol 2008 294 H1939 H1947. doi: 10.1152/ajpheart.00644.2007
196. Luckey SW, Mansoori J, Fair K, Antos CL, Olson EN, Leinwand LA, Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. Am J Physiol Heart Circ Physiol 2007 292 H838 H845. doi: 10.1152/ajpheart.00615.2006
197. Maass AH, Ikeda K, Oberdorf-Maass S, Maier SK, Leinwand LA, Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation 2004 110 2102 2109. doi: 10.1161/01.CIR.0000144460.84795.E3
198. Chen Y, Zhang Z, Hu F, Yang W, Yuan J, Cui J, Hao S, Hu J, Zhou Y, Qiao S, 17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: a preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation. J Steroid Biochem Mol Biol 2015 147 92 102. doi: 10.1016/j.jsbmb.2014.12.011
199. Najafi A, Schlossarek S, Van Deel ED, Van den Heuvel N, Güçlü A, Goebel M, Kuster DW, Carrier L, Van der Velden J, Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice. Pflugers Arch 2015 467 1303 1317. doi: 10.1007/s00424-014-1570-7
200. Arad M, Seidman JG, Seidman CE, Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 2002 11 2499 2506
201. Kubo T, Kitaoka H, Okawa M, Hirota T, Hayato K, Yamasaki N, Matsumura Y, Yabe T, Doi YL, Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study. J Cardiol 2010 56 314 319. doi: 10.1016/j.jjcc.2010.07.004
202. Zipes DP, Jalife J, Cardiac Electrophysiology: From Cell to Bedside 2013 6th ed Philadelphia: Elsevier Health Sciences